UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Exclusive] Patent of osteoarthritis drug Invossa refused in Europe
by Nam Doo-hyun
2018-10-30 16:04
CrystalGenomics to change molecular targeted therapy from injection to oral drug in trials
by Nam Doo-hyun
2018-10-30 10:52
‘Foreign investors fear Korean botox sales decline in China’
by Nam Doo-hyun
2018-10-29 16:52
‘Bio Solution’s value to rise on arthritis cell therapy’
by Nam Doo-hyun
2018-10-25 16:30
Novartis struggles to restore sales of Alzheimer’s drug Exelon
by Nam Doo-hyun
2018-10-25 11:04
라인
Will synthetic biology be vital in smart therapeutics?
by Nam Doo-hyun
2018-10-24 16:40
Biotech shares tank amid nosediving of Seoul stocks
by Nam Doo-hyun
2018-10-24 11:35
Anticoagulant Lixiana outpaces Eliquis in Q3 prescriptions
by Nam Doo-hyun
2018-10-23 16:10
‘Antibody drug developer AbClon noteworthy’
by Nam Doo-hyun
2018-10-22 14:49
'Superbug' fears bring antibiotics developers under spotlight
by Nam Doo-hyun
2018-10-22 11:53
라인
Bayer’s blood thinner wins broader indication for coronary artery disease
by Nam Doo-hyun
2018-10-19 16:34
Dental implant firms anticipate sales growth in H2
by Nam Doo-hyun
2018-10-18 14:52
‘Korea needs to toughen crackdown on illegal brokers for medical tourism’
by Nam Doo-hyun
2018-10-17 15:28
Relaxing requirement for innovative drugmakers will benefit Samsung, SK’
by Nam Doo-hyun
2018-10-17 14:38
CrystalGenomics hopes to test new leukemia drug early next year
by Nam Doo-hyun
2018-10-16 16:17
라인
Bio stocks listed under ‘tech exception policy’ perform better
by Nam Doo-hyun
2018-10-15 12:27
Anticipation grows for Lenvima as new liver cancer drug
by Nam Doo-hyun
2018-10-11 11:44
‘Korea publishes many biotech papers but rarely links them to biz’
by Nam Doo-hyun
2018-10-10 16:35
More biotech stocks come in top 20 on KOSDAQ
by Nam Doo-hyun
2018-10-10 11:20
‘Medytox performance depends on Chinese regulations on peddlers’
by Nam Doo-hyun
2018-10-08 16:59
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top